{"DataElement":{"publicId":"2639047","version":"1","preferredName":"Positron Emission Tomography Medical Imaging Lung Neoplasm Assessment Specify","preferredDefinition":"the free-text field to specify the anatomic site that postitron emmission tomography (PET), a medical imaging technique where a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom and when living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered, as the method of evaluation to determine the presence and location of an abnormal growth in a lung.","longName":"PET_MED_LNEO_ASS_SP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2639041","version":"1","preferredName":"Positron Emission Tomography Medical Imaging Lung Neoplasm Assessment","preferredDefinition":"information related to postitron emmission tomography (PET), a medical imaging technique where a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom and when living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered, as the method of evaluation to determine the presence and location of an abnormal growth in a lung.","longName":"PET_MEDIMG_LNEO_ASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2230957","version":"1","preferredName":"Positron Emission Tomography Medical Imaging","preferredDefinition":"A noninvasive imaging method that provides information about cellular activity (metabolic information).  It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information).:In medicine, any technology which helps in visualization of any biological process, cell, tissue or organ for the screening, diagnosis, surgical procedure or therapy.","longName":"C17007:C16831","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medical Imaging","conceptCode":"C16831","definition":"In medicine, any technology which helps in visualization of any biological process, cell, tissue or organ for the screening, diagnosis, surgical procedure or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7C5DB4E-ACCD-18B5-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-24","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-05-24","modifiedBy":"ONEDATA","dateModified":"2005-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2639039","version":"1","preferredName":"Lung Neoplasm Assessment","preferredDefinition":"Tumors or cancer of the LUNG.:Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C3200:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Neoplasm","conceptCode":"C3200","definition":"A benign or malignant, primary or metastatic neoplasm involving the lungs.  Representative examples of benign neoplasms include adenoma, papilloma, chondroma, and endobronchial lipoma.  Representative examples of malignant neoplasms include carcinoma, carcinoid tumor, sarcoma, and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30AC40E0-CC8C-4EED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-17","modifiedBy":"ONEDATA","dateModified":"2007-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30AC40E0-CC9D-4EED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2226669","version":"1","preferredName":"Anatomic Site Specify","preferredDefinition":"the free text field to specify an anatomic site.","longName":"ANATSITE_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600421C-68BC-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-09","modifiedBy":"CAMPBELB","dateModified":"2008-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Nodal lesion, specify","type":"Preferred Question Text","description":"Nodal lesion, specify","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"30ABDBB4-CE06-59BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-17","modifiedBy":"ALAIS","dateModified":"2009-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}